Panadeekarn Panjawatanan
Overview
Explore the profile of Panadeekarn Panjawatanan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
482
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ryabets-Lienhard A, Panjawatanan P, Vogt K, Ji J, Georgia S, Pitukcheewanont P
Calcif Tissue Int
. 2022 Dec;
112(4):518-523.
PMID: 36575358
Introduction: Progressive osseous heteroplasia (POH) is a rare, debilitating disorder characterized by heterotopic ossification in the skin and muscles, resulting in contractures of the joints and progressive loss of function....
2.
Wijarnpreecha K, Werlang M, Panjawatanan P, Pungpapong S, Lukens F, Harnois D, et al.
Indian J Med Res
. 2022 Jun;
154(6):806-812.
PMID: 35662085
Background & Objectives: Studies have suggested that smoking may accelerate the progression of fibrosis among patients with primary biliary cholangitis (PBC), although the data are limited. The current review was...
3.
Chang Villacreses M, Karnchanasorn R, Panjawatanan P, Ou H, Chiu K
J Clin Endocrinol Metab
. 2022 Apr;
107(7):e3086-e3087.
PMID: 35468193
No abstract available.
4.
Chang Villacreses M, Karnchanasorn R, Panjawatanan P, Ou H, Chiu K
World J Diabetes
. 2021 Oct;
12(9):1363-1385.
PMID: 34630895
As an endocrine hormone, vitamin D plays an important role in bone health and calcium homeostasis. Over the past two decades, the non-calcemic effects of vitamin D were extensively examined....
5.
Wijarnpreecha K, Aby E, Panjawatanan P, Lapumnuaypol K, Cheungpasitporn W, Lukens F, et al.
Ann Gastroenterol
. 2021 Jul;
34(4):568-574.
PMID: 34276197
Background: Recent studies have suggested an association between modest alcohol consumption and a decreased risk of advanced liver fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) although the results...
6.
Panjawatanan P, Charoenkwan P, Tantiworawit A, Strogatz D, Perry K, Tuntiwechapikul W
Blood Cells Mol Dis
. 2021 Apr;
89:102563.
PMID: 33798832
Hemoglobin H (Hb H) disease is the most significant health problem of the α-thalassemia syndromes. The Hb disease patients are categorized based on their genotype to deletional and nondeletional, with...
7.
Panjawatanan P, Jha S, Hughes J, Riesenfeld E
Cureus
. 2021 Jan;
12(11):e11805.
PMID: 33409050
Coronavirus disease 2019 (COVID-19) has been announced as a pandemic worldwide. The respiratory tract is a target organ system, where infection can result in serious complications, like acute respiratory distress...
8.
Wijarnpreecha K, Panjawatanan P, Kroner P, Cheungpasitporn W, Ungprasert P
Ann Gastroenterol
. 2020 Nov;
33(6):661-666.
PMID: 33162743
Background: Cardiovascular disease is a common comorbidity of patients with nonalcoholic fatty liver disease (NAFLD), particularly coronary artery disease and congestive heart failure. However, the relation between NAFLD and cardiac...
9.
Wijarnpreecha K, Panjawatanan P, Leelasinjaroen P, Ungprasert P
Arab J Gastroenterol
. 2020 Aug;
21(3):135-138.
PMID: 32830090
Background/objectives: Peptic ulcer disease (PUD) is one of the most common gastrointestinal disorders worldwide. Recent epidemiologic studies have suggested the protective effect of statins against the development of PUD although...
10.
Wijarnpreecha K, Ungprasert P, Panjawatanan P, Harnois D, Zaver H, Ahmed A, et al.
Eur J Gastroenterol Hepatol
. 2020 Jul;
33(7):990-995.
PMID: 32639420
Background/aims: The number of cases with coronavirus disease 2019 (COVID-19) has exceeded seven million worldwide. However, the data describing the global prevalence of liver injury associated with COVID-19 is lacking...